Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
45.32
+0.41 (0.91%)
Sep 18, 2024, 3:29 PM EDT - Market open
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $2.67 billion as of September 18, 2024. Its market cap has increased by 137.48% in one year.
Market Cap
2.67B
Enterprise Value
2.06B
1-Year Change
137.48%
Ranking
Category
Stock Price
$45.32
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.67B, an increase of 1,456.59%. That is a compound annual growth rate of 40.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 2.65B | 100.02% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 2.94B |
| Celldex Therapeutics | 2.93B |
| Concentra Group Holdings Parent | 2.93B |
| Tandem Diabetes Care | 2.88B |
| SpringWorks Therapeutics | 2.78B |
| Twist Bioscience | 2.75B |
| Geron | 2.72B |
| Inari Medical | 2.71B |